Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature

Introduction: Although pharmaceutical companies, regulatory authorities, and health technology assessment (HTA) agencies have been increasingly using decision-making frameworks, it is not certain whether these enable better quality decision making. This could be addressed by formally evaluating the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bujar, Magdalena, McAuslane, Neil, Walker, Stuart R., Salek, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385334/
https://www.ncbi.nlm.nih.gov/pubmed/28443022
http://dx.doi.org/10.3389/fphar.2017.00189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385334/
https://www.ncbi.nlm.nih.gov/pubmed/28443022
http://dx.doi.org/10.3389/fphar.2017.00189

Ejemplares similares